(ANSA-AFP) - ROME, SEPTEMBER 20 - The companies Pfizer and BioNTech have today announced that the results of clinical studies have shown that their vaccine against the coronavirus is "safe, well tolerated" and has produced a "robust" immune response in children aged between five and 11 years.
The companies have also announced that they will shortly request regulatory approval from regulatory bodies.
(ANSA-AFP).